Events racing forward at the speed of mach2
|
5
|
Resverlogix Corp.
|
Apr 13, 2017 01:40PM
|
Re: 3rd Quarter Financial Statements
|
5
|
Resverlogix Corp.
|
Mar 15, 2017 06:05PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
5
|
Resverlogix Corp.
|
Apr 15, 2021 05:00PM
|
Re: Any day now......
|
5
|
Resverlogix Corp.
|
May 28, 2021 12:57PM
|
Re: Market:FDA Not Enough ??
|
5
|
Resverlogix Corp.
|
Jul 25, 2017 11:02AM
|
Share Price Contest
|
5
|
Resverlogix Corp.
|
Nov 19, 2019 02:48PM
|
Re: Insider Selling
|
5
|
Resverlogix Corp.
|
Jul 13, 2019 08:18PM
|
Re: got this & sent a response/follow up minutes before …
|
5
|
Zenith Epigenetics
|
Dec 12, 2023 01:47PM
|
Re: Right of first refusal
|
5
|
Resverlogix Corp.
|
Mar 02, 2019 03:40PM
|
Re: Hello
|
5
|
Resverlogix Corp.
|
Feb 16, 2022 04:11PM
|
4th of July
|
5
|
Resverlogix Corp.
|
Jul 04, 2017 08:41AM
|
Re: Looking at the chart...introducing the bullish channel
|
5
|
Resverlogix Corp.
|
Sep 21, 2018 01:32AM
|
Re: you won’t see anyone buying this
|
5
|
Zenith Epigenetics
|
Dec 06, 2023 08:53PM
|
Re: It Pays to Wait ......
|
5
|
Resverlogix Corp.
|
Feb 04, 2019 04:17PM
|
Re: Stock Alert
|
5
|
Resverlogix Corp.
|
Feb 09, 2018 05:27PM
|
Story time with tada
|
5
|
Resverlogix Corp.
|
Feb 15, 2018 05:55PM
|
Re: Heavier than normal trading on the OTC for RVXCF
|
5
|
Resverlogix Corp.
|
Mar 15, 2017 08:46PM
|
Re: BETonMACE Placebo Estimate
|
5
|
Resverlogix Corp.
|
Feb 20, 2019 01:11PM
|
Re: ZEN-3694 mCRPC Trial Status
|
5
|
Zenith Epigenetics
|
Nov 18, 2017 07:45PM
|
Re: Right of first refusal
|
5
|
Resverlogix Corp.
|
Mar 02, 2019 10:31PM
|